Missing Avatar

Adolfo Rivero Muller

  • Adolfo Rivero Muller hasn't added any employment information yet...

  • Adolfo Rivero Muller hasn't added any educational information yet...

Publication Info
A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3. Rahman NA, Bennink HJ, Chrusciel M, Sharp V, Zimmerman Y, Dina R, Li X and 6 others FASEB J. 26(1):324-33. doi: 10.1096/fj.11-192468. January 2012. View on PubMed.
Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels. Ahtiainen P, Sharp V, Rulli SB, Rivero-Müller A, Mamaeva V, Röyttä M, Huhtaniemi I Endocr Relat Cancer. 17(3):611-21. doi: 10.1677/ERC-10-0016. June 3, 2010. View on PubMed.
Consequences of genetic manipulations of gonadotrophins and gonadotrophin receptors in mice. Peltoketo H, Rivero-Müller A, Ahtiainen P, Poutanen M, Huhtaniemi I Ann Endocrinol (Paris). 71(3):170-6. doi: 10.1016/j.ando.2010.02.022. April 2, 2010. View on PubMed.
Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis. Peuhu E, Rivero-Müller A, Stykki H, Torvaldson E, Holmbom T, Eklund P, Unkila M, Sjöholm R, Eriksson JE Oncogene. 29(6):898-908. doi: 10.1038/onc.2009.386. February 11, 2010. View on PubMed.
Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Rivero-Müller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH, Huhtaniemi I Proc Natl Acad Sci U S A. 107(5):2319-24. doi: 10.1073/pnas.0906695106. February 2, 2010. View on PubMed.
Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate. Vuorenoja S, Rivero-Müller A, Ziecik AJ, Huhtaniemi I, Toppari J, Rahman NA Endocr Relat Cancer. 15(2):635-48. doi: 10.1677/ERC-08-0015. June 2008. View on PubMed.
Assisted large fragment insertion by Red/ET-recombination (ALFIRE)--an alternative and enhanced method for large fragment recombineering. Rivero-Müller A, Lajić S, Huhtaniemi I Nucleic Acids Res. 35(10):e78. doi: 10.1093/nar/gkm250. May 21, 2007. View on PubMed.
Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors. Rivero-Müller A, Vuorenoja S, Tuominen M, Wacławik A, Brokken LJ, Ziecik AJ, Huhtaniemi I, Rahman NA Mol Cell Endocrinol. 269(1-2):17-25. doi: 10.1016/j.mce.2006.11.016. April 15, 2007. View on PubMed.
Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6. Vuorenoja S, Rivero-Muller A, Kiiveri S, Bielinska M, Heikinheimo M, Wilson DB, Huhtaniemi IT, Rahman NA Mol Cell Endocrinol. 269(1-2):38-45. doi: 10.1016/j.mce.2006.11.013. April 15, 2007. View on PubMed.
Mixed chelate copper complex, Casiopeina IIgly, binds and degrades nucleic acids: a mechanism of cytotoxicity. Rivero-Müller A, De Vizcaya-Ruiz A, Plant N, Ruiz L, Dobrota M Chem Biol Interact. 165(3):189-99. doi: 10.1016/j.cbi.2006.12.002. February 20, 2007. View on PubMed.
Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells. An BS, Selva DM, Hammond GL, Rivero-Muller A, Rahman N, Leung PC J Biol Chem. 281(30):20817-24. doi: 10.1074/jbc.M600743200. July 28, 2006. View on PubMed.
The regulated expression of c-IAP1 and c-IAP2 during the rat seminiferous epithelial cycle plays a role in the protection of germ cells from Fas-mediated apoptosis. Wang Y, Suominen JS, Parvinen M, Rivero-Muller A, Kiiveri S, Heikinheimo M, Robbins I, Toppari J Mol Cell Endocrinol. 245(1-2):111-20. doi: 10.1016/j.mce.2005.11.004. December 21, 2005. View on PubMed.
Molecular cloning and spatiotemporal expression of prostaglandin F synthase and microsomal prostaglandin E synthase-1 in porcine endometrium. Waclawik A, Rivero-Muller A, Blitek A, Kaczmarek MM, Brokken LJ, Watanabe K, Rahman NA, Ziecik AJ Endocrinology. 147(1):210-21. doi: 10.1210/en.2005-0880. October 13, 2005. View on PubMed.
A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice. Bodek G, Vierre S, Rivero-Müller A, Huhtaniemi I, Ziecik AJ, Rahman NA Neoplasia. 7(5):497-508. May 2005. View on PubMed.
Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4. Rahman NA, Kiiveri S, Rivero-Müller A, Levallet J, Vierre S, Kero J, Wilson DB, Heikinheimo M, Huhtaniemi I Mol Endocrinol. 18(10):2553-69. doi: 10.1210/me.2002-0282. July 15, 2004. View on PubMed.
Hematotoxicity response in rats by the novel copper-based anticancer agent: casiopeina II. De Vizcaya-Ruiz A, Rivero-Müller A, Ruiz-Ramirez L, Howarth JA, Dobrota M Toxicology. 194(1-2):103-13. December 15, 2003. View on PubMed.
Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis. Tran SE, Meinander A, Holmström TH, Rivero-Müller A, Heiskanen KM, Linnau EK, Courtney MJ, Mosser DD, Sistonen L, Eriksson JE Cell Death Differ. 10(10):1137-47. doi: 10.1038/sj.cdd.4401278. October 2003. View on PubMed.
Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells. De Vizcaya-Ruiz A, Rivero-Muller A, Ruiz-Ramirez L, Kass GE, Kelland LR, Orr RM, Dobrota M Toxicol In Vitro. 14(1):1-5. February 2000. View on PubMed.
  • Adolfo Rivero Muller hasn't received any ratings yet...